Masaki Nagane

7PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsFood properties (incl. characteristics and health benefits)GlycoconjugatesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 06, 2025
Inhibition of Ferroptosis Enhances Anticancer Effect of Magnetized-Natural Killer Cell Therapy.

Masaki Nagane, Hayato Shinohara, Norio Kaneko

|Dec 31, 2024
Hypoxia-induced increase in sphingomyelin synthase 2 aggravates ischemic skeletal muscle inflammation.

Hinano Mizugaki, Masaki Nagane, Hideo Sato-Akaba

|Aug 07, 2023
Prebiotic effect of poly-D-3-hydroxybutyrate prevents dyslipidemia in obese mice.

Mayuko Mishima, Shiro Takeda, Masaki Nagane

|Apr 26, 2023
Ganglioside GM3 deficiency enhances mast cell sensitivity.

Mariko Komuro, Hinano Mizugaki, Masaki Nagane

|Dec 23, 2022
The novel sustained 3-hydroxybutyrate donor poly-D-3-hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T-cells.

Rimina Suzuki, Mayuko Mishima, Masaki Nagane

|Oct 18, 2021
Flower lose, a cell fitness marker, predicts COVID-19 prognosis.

Michail Yekelchyk, Esha Madan, Jochen Wilhelm

Pageof 2